Co-Authors
This is a "connection" page, showing publications co-authored by RANDAL S WEBER and EHAB Y HANNA.
Connection Strength
2.551
-
Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis. Mod Pathol. 2024 Jan; 37(1):100372.
Score: 0.242
-
High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol. 2020 Dec; 49:151622.
Score: 0.195
-
Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. Head Neck. 2019 09; 41(9):3090-3104.
Score: 0.177
-
Cellular subtype may predict survival outcomes in salivary adenoid cystic carcinoma patients-a single-institution experience. Virchows Arch. 2018 Mar; 472(3):505-512.
Score: 0.160
-
Addendum to Bell et al's "In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type". Cancer. 2016 07 15; 122(14):2278-9.
Score: 0.144
-
In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer. 2016 May 15; 122(10):1513-22.
Score: 0.143
-
Quality of care in head and neck cancer. Curr Oncol Rep. 2011 Apr; 13(2):120-5.
Score: 0.101
-
Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011 Jan; 137(1):78-81.
Score: 0.100
-
Quality and performance indicators in an academic department of head and neck surgery. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1212-8.
Score: 0.099
-
Compliance with quality assurance measures in patients treated for early oral tongue cancer. Cancer. 2010 Jul 15; 116(14):3408-16.
Score: 0.096
-
Academic productivity in otolaryngology. Otolaryngol Head Neck Surg. 2008 Apr; 138(4):546; author reply 546-7.
Score: 0.082
-
Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31.
Score: 0.081
-
Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol. 2022 11; 134:106127.
Score: 0.056
-
The tumor immune contexture of salivary duct carcinoma. Head Neck. 2021 04; 43(4):1213-1219.
Score: 0.050
-
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
Score: 0.048
-
Reducing patient wait times in a head and neck cancer outpatient clinic: A pilot study. Laryngoscope. 2020 04; 130(4):E151-E154.
Score: 0.044
-
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1941.
Score: 0.043
-
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1942.
Score: 0.043
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654.
Score: 0.043
-
Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program. J Oncol Pract. 2018 02; 14(2):e103-e112.
Score: 0.040
-
Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 11 23; 12(1):186.
Score: 0.040
-
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
Score: 0.040
-
Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016 04; 38 Suppl 1:E2259-66.
Score: 0.034
-
Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biol Ther. 2015; 16(6):834-8.
Score: 0.034
-
Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
Score: 0.034
-
Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol. 2015 Jun; 19(3):154-6.
Score: 0.033
-
Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015 Jun; 51(6):610-5.
Score: 0.033
-
Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands. Ann Surg Oncol. 2015 Oct; 22(11):3701-7.
Score: 0.033
-
Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. Ann Diagn Pathol. 2014 Feb; 18(1):10-3.
Score: 0.030
-
Primary sarcomas of the salivary glands: case series and literature review. Head Neck. 2013 Nov; 35(11):1551-7.
Score: 0.029
-
Developing a system to track meaningful outcome measures in head and neck cancer treatment. Head Neck. 2014 Feb; 36(2):226-30.
Score: 0.029
-
ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma. Head Neck. 2013 Apr; 35(4):575-8.
Score: 0.027
-
Minor salivary gland malignancies in the pediatric population. Head Neck. 2012 Nov; 34(11):1648-51.
Score: 0.027
-
Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012 Aug 15; 118(16):3928-36.
Score: 0.027
-
Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 2012 Jun 01; 118(11):2872-8.
Score: 0.026
-
Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011 Oct 01; 12(7):569-73.
Score: 0.026
-
Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck. 2011 Dec; 33(12):1769-73.
Score: 0.025
-
Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):401-6.
Score: 0.020
-
Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol. 2005 Mar; 18(3):315-9.
Score: 0.017